Noga Yerushalmi serves as the Investment Director and Head of the Israel Bio-incubator at M Ventures since January 2018, alongside roles as Head of PMatX since February 2019 and a Consultant for Life Sciences since January 2017. With extensive experience in various leadership positions, Yerushalmi was Co-Founder of DYNOVLY LTD, Director of Business Development at FutuRx, VP of R&D at miCure Therapeutics, and Senior Director of Cancer Drug Discovery at Rosetta Genomics. Yerushalmi's educational background includes a postdoctoral fellowship in Molecular Biology at NCI-NIH and a PhD in Biochemistry from Tel Aviv University. Additionally, foundational studies in Biology occurred at Tel Aviv University.